Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02959437
Title Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of California San Diego La Jolla California 92093 United States Details
The University of Chicago Chicago Illinois 60637 United States Details
University of Pennsylvania Health System Philadelphia Pennsylvania 19014 United States Details
Sarah Cannon Nashville Tennessee 37203 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Washington Seattle Washington 98109 United States Details
Vall D Hebron Univ Barcelona 08035 Spain Details
Univ De Navarra Pamplona 31008 Spain Details
University College London Hospitals (Uclh) London W1t7ha United Kingdom Details
Churchill Hospital Oxford Ox37le United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field